Helicobacter pylori babA2 Positivity Predicts Risk of Gastric Cancer in Ardabil, a Very High-Risk Area in Iran

  • Abdi, Esmat (Department of Biology, Faculty of Sciences, Ardabil University of Medical Sciences) ;
  • Latifi-Navid, Saeid (Department of Biology, Faculty of Sciences, Ardabil University of Medical Sciences) ;
  • Yazdanbod, Abbas (Gastrointestinal Cancer Research Center, Ardabil University of Medical Sciences) ;
  • Zahri, Saber (Department of Biology, Faculty of Sciences, Ardabil University of Medical Sciences)
  • Published : 2016.03.07


Background: Ardabil, a Northwestern province of Iran, was found to have the highest rate of gastric cancer (GC) in the country (ASRs = 51.8/100,000 for males and 24.9/100,000 for females) and one of the highest gastric cardia cancer rates in the world. The aim of the present study was to assess the associations of the cagA and babA2 status of Helicobacter pylori with GC in the Ardabil population. Materials and Methods: A total of 103 patients with non-atrophic gastritis (56) and GC (47), who underwent endoscopy at the Imam Khomeini Hospital in Ardabil, were assessed. The status of 16S rDNA, cagA and babA2 genes was determined using PCR and histopathological assessment was performed. Results: The following genotypic frequency was observed: cagA+ (50.6%), cagA-(49.4%), babA2+ (26.5%), babA2- (73.5%) cagA+/babA2+ (19.3%), cagA-/babA2+ (7.2%), cagA+/babA2-(31.3%), cagA-/babA2-(42.2%). Although the frequency of the cagA+, cagA+/babA2+ and cagA-/babA2+ genotypes in patients with GC (55.6%, 25.9%, and 14.8%, respectively) was higher than in those with NAG (48.2%, 16.1%, and 3.6%, respectively), the difference did not reach significance. In contrast, the presence of the babA2 gene (40.7% vs 19.6%) significantly increased the risk of GC; the age-sex-adjusted odds ratio (95% confidence interval) was 5.068 (1.506-17.058; P=0.009), by multiple logistic regression. Conclusions: It is proposed that the H. pylori babA2 positivity might be considered as an important determinant of GC risk in Ardabil.


Supported by : University of Mohaghegh Ardabili


  1. Abadi ATB, Taghvaei T, Mobarez AM, et al (2013). High correlation of babA 2-positive strains of Helicobacter pylori with the presence of gastric cancer. Internal and Emergency Med, 8, 497-501.
  2. Abasiyanik MF, Sander E, Salih BA (2002). Helicobacter pylori anti-CagA antibodies: prevalence in symptomatic and asymptomatic subjects in Turkey. Canadian journal of gastroenterology= Journal canadien de gastroenterologie, 16, 527-32.
  3. Alireza S, Mehdi N, Ali M, et al (2005a). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
  4. Alireza S, Mehdi N, Ali M, et al (2005b). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359.
  5. Argent RH, Hale JL, El-Omar EM, et al (2008). Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol, 57, 1062-7.
  6. Azevedo M, Eriksson S, Mendes N, et al (2008). Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol, 215, 308-16.
  7. Babaei M, Jaafarzadeh H, Sadjadi A, et al (2009). Cancer incidence and mortality in Ardabil: Report of an ongoing population-based cancer registry in Iran, 2004-2006. Iranian Journal of Public Health, 38, 35-45.
  8. Babaei M, Pourfarzi F, Yazdanbod A, et al (2010). Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. Asian Pac J Cancer Prev, 11, 595-9.
  9. Bagheri N, Taghikhani A, Rahimian G, et al (2013). Association between virulence factors of Helicobacter pylori and gastric mucosal interleukin-18 mRNA expression in dyspeptic patients. Microbial pathogenesis, 65, 7-13.
  10. Bakhti SZ, Latifi-Navid S, Mohammadi S, et al (2015). Relevance of Helicobacter pylori vacA 3-end Region Polymorphism to Gastric Cancer. Helicobacter.
  11. Basso D, Zambon CF, Letley DP, et al (2008). Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology, 135, 91-9.
  12. Cavalcante MQdF, Silva CIS, Braga-Neto MB, et al (2012). Helicobacter pylori vacA and cagA genotypes in patients from northeastern Brazil with upper gastrointestinal diseases. Memorias do Instituto Oswaldo Cruz, 107, 561-3.
  13. Chang WL, Yang HB, Cheng HC, et al (2015). Intracellular Osteopontin Induced by CagA-positive Helicobacter pylori Promotes Beta-catenin accumulation and interleukin-8 secretion in gastric epithelial cells. Helicobacter.
  14. Chen XZ, Wang R, Chen HN, et al (2015). Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer: A meta-analysis based on nested case-control studies. Pancreas, 44, 1340-4.
  15. Chomvarin C, Namwat W, Chaicumpar K, et al (2008). Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis, 12, 30-6.
  16. Cittelly D, Huertas M, Martinez J, et al (2002). [Helicobacter pylori genotypes in non atrophic gastritis are different of the found in peptic ulcer, premalignant lesions and gastric cancer in Colombia]. Revista medica de Chile, 130, 143-51.
  17. Dabiri H, Maleknejad P, Yamaoka Y, et al (2009). Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran. Journal of gastroenterology and hepatology, 24, 1380-6.
  18. Dabrii H, Bolfion M, Mirsalehian A, et al (2010). Analysis of Helicobacter pylori genotypes in Afghani and Iranian isolates. Polish journal of microbiology/Polskie Towarzystwo Mikrobiologow= The Polish Society of Microbiologists, 59, 61-6.
  19. Derakhshan M, Yazdanbod A, Sadjadi A, et al (2004). High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut, 53, 1262-6.
  20. Dixon MF, Genta RM, Yardley JH, et al (1996). Classification and grading of gastritis: the updated Sydney system. The American journal of surgical pathology, 20, 1161-81.
  21. Erzin Y, Koksal V, Altun S, et al (2006). Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter, 11, 574-80.
  22. Erzin Y, Koksal V, Altun S, et al (2008). Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia. J Gastroenterol, 43, 705-10.
  23. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86.
  24. Ferreira RM, Pinto-Ribeiro I, Wen X, et al (2015). Helicobacter pylori cagA promoter region sequences influence CagA Expression and Interleukin 8 Secretion. J Infect Dis.
  25. Figueiredo C, Machado JC, Pharoah P, et al (2002). Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst, 94, 1680-7.
  26. Gatti LL, Modena JL, Payao SL, et al (2006). Prevalence of Helicobacter pylori cagA, iceA and babA2 alleles in Brazilian patients with upper gastrointestinal diseases. Acta Trop, 100, 232-40.
  27. Gerhard M, Lehn N, Neumayer N, et al (1999). Clinical relevance of the Helicobacter pylori gene for blood-group antigenbinding adhesin. Proceedings of the National Academy of Sciences, 96, 12778-83.
  28. González CA, Figueiredo C, Lic CB, et al (2011). Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. The American J Gastroenterol, 106, 867-74.
  29. Hansson LE, Nyren O, Hsing AW, et al (1996). The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med, 335, 242-9.
  30. Honarmand-Jahromy S, Siavoshi F, Malekzadeh R, et al (2015). Multiple repeats of Helicobacter pylori CagA EPIYA-C phosphorylation sites predict risk of gastric ulcer in Iran. Microb Pathog, 89, 87-92.
  31. Ilver D, Arnqvist A, Ogren J, et al (1998). Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science, 279, 373-7.
  32. Jafari F, Shokrzadeh L, Dabiri H, et al (2008). vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Japanese journal of infectious diseases, 61, 290-3.
  33. Joober R, Schmitz N, Annable L, et al (2012). Publication bias:What are the challenges and can they be overcome? Journal of psychiatry & neuroscience: JPN, 37, 149-52.
  34. Kim SY, Woo CW, Lee YM, et al (2001). Genotyping CagA, VacA subtype, IceA1, and BabA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases. Journal of Korean medical science, 16, 579-84.
  35. Latifi-Navid S, Ghorashi SA, Siavoshi F, et al (2010). Ethnic and geographic differentiation of Helicobacter pylori within Iran. PLoS One, 5, 9645.
  36. Latifi-Navid S, Mohammadi S, Maleki P, et al (2013). Helicobacter pylori vacA d1/-i1 genotypes and geographic differentiation between high and low incidence areas of gastric cancer in Iran. Archives of Iranian Med, 16, 330-7.
  37. Lee H, Choe G, Kim W, et al (2006). Expression of Lewis antigens and their precursors in gastric mucosa: relationship with Helicobacter pylori infection and gastric carcinogenesis. The J Pathol, 209, 88-94.
  38. Leung WK, Chan MC, To K-F, et al (2006). H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. The American J Gastroenterol, 101, 714-20.
  39. Lu Y, Redlinger TE, Avitia R, et al (2002). Isolation and genotyping of Helicobacter pylori from untreated municipal wastewater. Applied and Environmental Microbiol, 68, 1436-9.
  40. Malekzadeh R, Sotoudeh M, Derakhshan M, et al (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clinical Pathol, 57, 37-42.
  41. Matsunari O, Shiota S, Suzuki R, et al (2012). Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clinical Microbiol, 50, 876-83.
  42. Mattar R, Marques SB, do Socorro Monteiro M, et al (2007). Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. Journal of medical microbiology, 56, 9-14.
  43. Nouraie M, Latifi-Navid S, Rezvan H, et al (2009). Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter, 14, 40-6.
  44. Ohnishi N, Yuasa H, Tanaka S, et al (2008). Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proceedings of the National Academy of Sciences, 105, 1003-8.
  45. Peek RM, Jr., Fiske C, Wilson KT (2010). Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev, 90, 831-58.
  46. Raei N, Latifi-Navid S, Zahri S (2015). Helicobacter pylori cag Pathogenicity Island cagL and orf17 Genotypes predict risk of peptic ulcerations but not gastric cancer in Iran. Asian Pac J Cancer Prev, 16, 6645-50.
  47. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: Results of a population-based Cancer Registry from Iran. Intern J Cancer, 107, 113-8.
  48. Sicinschi L, Correa P, Peek R, et al (2010). CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clinical Microbiology and Infection, 16, 369-78.
  49. Sozzi M, Tomasini ML, Vindigni C, et al (2005). Heterogeneity of cag genotypes and clinical outcome of Helicobacter pylori infection. J Laboratory Clin Med, 146, 262-70.
  50. Suerbaum S, Michetti P (2002). Helicobacter pylori infection. New England J Med, 347, 1175-86.
  51. Tan HJ, Rizal AM, Rosmadi MY, et al (2006). Role of Helicobacter pylori virulence factor and genotypes in nonulcer dyspepsia. J gastroenterol hepatol, 21, 110-5.
  52. Yong X, Tang B, Li BS, et al (2015). Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun Signal, 13, 30.
  53. Zhao Z, Li Y, Liu S, et al (2014). Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries. Tumour Biol, 35, 12217-24.